Clinical Trials Browser

Pharmaceutical Services × Other hematologic neoplasm × Clear all

NCT03090477 2019-04-05

Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients

Phase NA Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Medication Adherence